iCamuno Biotherapeutics
PrivateLast Round
VC Round
Sep 22, 2023
Total Funding Raised
$100.3M
Company Overview
iCamuno Biotherapeutics is a biotechnology company that develops cell therapies using induced pluripotent stem cells (iPSC), gene editing, and cellular differentiation technologies for applications in tumor immunology and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iCamuno Biotherapeutics Comparables
Compare iCamuno Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cartherics | 91% | |
| HebeCell | 84% | |
| Neukio Biotherapeutics | 84% |
iCamuno Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 22, 2023 | ||||
| Series A Extension | Mar 29, 2021 | ||||
| Series A Extension | Sep 23, 2019 | ||||
| Series A | Jul 23, 2018 |
iCamuno Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Legend Star | Series A Extension |
| 招银国际金融有限公司 | Series A Extension |
| ARCH Venture Partners | Series A |
| Northern Light Venture Capital | VC Round, Series A, Series A Extension |
| 西湖科创投 | VC Round |
| BC Capital | Series A Extension |
| Biomatics Capital Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 2, 2026
Monthly visitors increased 69% MoM.
- Sep 22, 2023
$16M round led by Zhejiang Provincial Industrial Fund
iCamuno Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about iCamuno Biotherapeutics's valuation, stock price, and market status.
Is iCamuno Biotherapeutics a public or private company?
iCamuno Biotherapeutics is a private company.
What is the current stock price of iCamuno Biotherapeutics?
iCamuno Biotherapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is iCamuno Biotherapeutics worth (valuation)?
Valuation information for iCamuno Biotherapeutics is not publicly available.
Can I buy iCamuno Biotherapeutics stock?
iCamuno Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was iCamuno Biotherapeutics's last funding round?
iCamuno Biotherapeutics's most recent funding round was VC Round on September 22, 2023.
Who are the main investors in iCamuno Biotherapeutics?
Key investors in iCamuno Biotherapeutics include 招银国际金融有限公司, HongShan, MPCi, Lilly Asia Ventures, Zhejiang Provincial Industrial Fund.
Will iCamuno Biotherapeutics IPO soon?
No public IPO plans have been announced for iCamuno Biotherapeutics.
How can I track iCamuno Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor iCamuno Biotherapeutics's secondary market activity and sign up for updates.